We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603259:SSEWuXi AppTec Co., Ltd. Class A Analysis

Data as of 2026-09-01 - not real-time

CN¥154.40

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At ¥154.40, WuXi AppTec Co., Ltd. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 22.1% over the past 30 days. With RSI at 53.8 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at ¥141.45 and resistance at ¥173.60.
The shares look undervalued, trading on 20.9 times earnings below a sector average of 30.6. Consensus targets land 19.1% above where the shares trade now. The 1.35% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 50.8%, a beta of 0.51 and a maximum drawdown of 22.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.

Top Market Events

SHANGHAI, Aug. 3, 2026 /PRNewswire/ -- WuXi AppTec stock code: 603259.SH / 2359.HK , a leading global pharmaceutical...On the evening of August 9, WuXi AppTec Co.Total Revenue Reached RMB 12.44 Billion; Revenue from Continuing Operations Up 39.4% YoY Adjusted Non-IFRS Net Profit...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 107.81
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 20.9 versus sector average of 30.6
  • Trading above the 200-day average of 107.81

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 20.9 versus sector average of 30.6
  • Analyst targets imply +19.1% versus the current price
  • Profit margin of 42.3% is healthy

Key Metrics & Analysis

Financial Health

Profit Margin42.26%
P/E Ratio20.9
ROE28.37%
ROA13.95%
Debt/Equity18.02
P/B Ratio5.4
Op. Cash FlowCN¥19.5B
Free Cash FlowCN¥9.6B
Industry P/E30.6

Technical Analysis

TrendBullish
RSI53.8
SupportCN¥141.45
ResistanceCN¥173.60
MA 20CN¥158.93
MA 50CN¥138.06
MA 200CN¥107.81
MACDBearish
VolumeDecreasing
Fear & Greed Index92.25

Valuation

Fair ValueCN¥51.80
Target PriceCN¥183.92
Upside/Downside19.12%
GradeUndervalued
TypeBlend
Dividend Yield1.35%

Risk Assessment

Beta0.51
Volatility50.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.